Intermittent claudication: Functional capacity and quality of life after exercise training or percutaneous transluminal angioplasty - Systematic review

Radiology

Volumn 235, Issue 3, 2005, Pages 833-842

  Spronk, Sandra ^a   Bosch, Johanna L ^b,c   Veen, Hermanus F ^a   Den Hoed, Pieter T ^a   Hunink, M G Myriam ^b,d  

^a IKAZIA HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKLE BRACHIAL INDEX; CLINICAL TRIAL; EXERCISE; FOLLOW UP; FUNCTION TEST; HEALTH SURVEY; HUMAN; INTERMITTENT CLAUDICATION; PAIN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SHORT FORM 36; STUDENT T TEST; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; MALE; QUALITY OF LIFE; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 18844379713     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2353040457     Document Type: Review

References (47)

1. Dormandy J, Mahir M, Ascady G, et al. Fate of the patient with chronic leg ischaemia: a review article. J Cardiovasc Surg (Torino) 1989; 30:50-57.
2. Balkau B, Vray M, Eschwege E. Epidemiology of peripheral arterial disease. J Cardiovasc Pharmacol 1994; 23(suppl 3):S8-S16.
3. U.S. Department of Commerce, Bureau of the Census. Projections of the population of the United States by age, sex and race: 1983-2080. In: Current population reports, population estimates and projections. Series P-25, no. 952. Washington, DC, 1984.
4. Foley WT. Treatment of gangrene of the feet and legs by walking. Circulation 1957; 15:689-700.
5. Ekroth R, Dahllof AG, Gundevall B, Holm J, Schersten T. Physical training of patients with intermittent claudication: indications, methods, and results. Surgery 1978; 84:640-643.
6. Larsen OA, Lassen NA. Effect of daily muscular exercise in patients with intermittent claudication. Lancet 1966; 2: 1093-1096.
7. Skinner JS, Strandness DE. Exercise and intermittent claudication: effect of physical training. Circulation 1967; 36:23-29.
8. Regensteiner JG, Hiatt WR. Exercise rehabilitation for patients with peripheral arterial disease. Exerc Sport Sci Rev 1995; 23:1-24.
9. Regensteiner JG. Exercise in the treatment of claudication: assessment and treatment of functional impairment. Vasc Med 1997; 2:238-242.
10. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction: description of a new technic and a preliminary report of its application. Circulation 1964; 30:654-670.
11. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 1994; 14:71-81.
12. Bosch JL, van der Graaf Y, Hunink MG. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. Circulation 1999; 99:3155-3160.
13. Muradin GS, Bosch JL, Stijnen T, Hunink MG. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 2001; 221:137-145.
14. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204:87-96.
15. Jansen RM, de Vries SO, Cullen KA, Donaldson MC, Hunink MG. Cost-identification analysis of revascularization procedures on patients with peripheral arterial occlusive disease. J Vasc Surg 1998; 28:617-623.
16. Bosch JL, Haaring C, Meyerovitz MF, Cullen KA, Hunink MG. Cost-effectiveness of percutaneous treatment of iliac artery occlusive disease in the United States. AJR Am J Roentgenol 2000; 175: 517-521.
17. de Vries SO, Visser K, de Vries JA, Wong JB, Donaldson MC, Hunink MG. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. Radiology 2002; 222:25-36.
18. Guyatt GH, Veldhuyzen Van Zanten SJ, Feeny DH, Patrick DL. Measuring quality of life in clinical trials: a taxonomy and review. CMAJ 1989; 140:1441-1448.
19. Schroeder TV. The TASC supplement: international recommendations for management of peripheral arterial disease [editorial]. Eur J Vasc Endovasc Surg 2000; 19:563.
20. de Vries SO, Kuipers WD, Hunink MG. Intermittent claudication: symptom severity versus health values. J Vasc Surg 1998; 27:422-430.
21. Feinglass J, McCarthy WJ, Slavensky R, Manheim LM, Martin GJ. Effect of lower extremity blood pressure on physical functioning in patients who have intermittent claudication. The Chicago Claudication Outcomes Research Group. J Vasc Surg 1996; 24:503-511.
22. Moher D, Pham B, Klassen TP, et al. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol 2000; 53:964-972.
23. Klevsgard R, Hallberg IR, Risberg B, Thomsen MB. The effects of successful intervention on quality of life in patients with varying degrees of lower-limb ischaemia. Eur J Vasc Endovasc Surg 2000; 19:238-245.
24. Klevsgard R, Risberg BO, Thomsen MB, Hallberg IR. A 1-year follow-up quality of life study after hemodynamically successful or unsuccessful surgical revascularization of lower limb ischemia. J Vasc Surg 2001; 33:114-122.
25. Chetter IC, Spark JI, Kent PJ, Berridge DC, Scott DJ, Kester RC. Percutaneous transluminal angioplasty for intermittent claudication: evidence on which to base the medicine. Eur J Vasc Endovasc Surg 1998; 16:477-484.
26. Chetter IC, Spark JI, Scott DJ, Kester RC. Does angioplasty improve the quality of life for claudicants? a prospective study. Ann Vasc Surg 1999; 13:93-103.
27. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for claudication: assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation 1995; 92:614-621.
28. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form health survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31:247-263.
29. Bosch JL, Hunink MG. The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication. Med Decis Making 1996; 16:217-225.
30. Laird NM, Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care 1990; 6:5-30.
31. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634.
32. Whyman MR, Fowkes FG, Kerracher EM, et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg 1996; 12:167-172.
33. Gartenmann C, Kirchberger I, Herzig M, et al. Effects of exercise training program on functional capacity and quality of life in patients with peripheral arterial occlusive disease: evaluation of a pilot project. Vasa 2002; 31:29-34.
34. Currie IC, Wilson YG, Baird RN, Lamont PM. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 1995; 10:356-361.
35. Gardner AW, Katzel LI, Sorkin JD, et al. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc 2001; 49:755-762.
36. Patterson RB, Pinto B, Marcus B, Colucci A, Braun T, Roberts M. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg 1997; 25:312-318; discussion 318-319.
37. Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 1997; 48:291-300.
38. Savage P, Ricci MA, Lynn M, et al. Effects of home versus supervised exercise for patients with intermittent claudication. J Cardiopulm Rehabil 2001; 21:152-157.
39. Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? preliminary results from a prospective randomised trial. Eur J Vasc Surg 1990; 4:135-140.
40. Whyman MR, Fowkes FG, Kerracher EM, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? a randomized controlled trial. J Vasc Surg 1997; 26:551-557.
41. Fowkes FG, Gillespie IN. Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database Syst Rev 2000; 2:CD000017.
42. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease: implications for the mechanism of the training response. Circulation 1994; 90: 1866-1874.
43. Jonason T, Ringqvist I, Oman-Rydberg A. Home-training of patients with intermittent claudication. Scand J Rehabil Med 1981; 13:137-141.
44. Gold M. Panel on cost-effectiveness in health and medicine. Med Care 1996; 34(suppl 12):DS197-DS199.
45. Rose G, McGartner P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977; 31:42-48.
46. Tetteroo E, van der Graaf Y, Bosch JL, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 1998; 351:1153-1159.
47. Klein WM, Buskens E, van der Graaf M, Mali WPTM. Peripheral arterial disease: diagnosis, treatment and prognosis [thesis]. Utrecht, the Netherlands: University of Utrecht, 2003.